• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺导管腺癌源自非典型扁平病变:转基因小鼠和人组织的对比研究。

Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.

机构信息

Institute of Pathology, Helmholtz Zentrum München, Neuherberg, Germany.

出版信息

J Pathol. 2012 Apr;226(5):723-34. doi: 10.1002/path.3017. Epub 2012 Jan 17.

DOI:10.1002/path.3017
PMID:21984419
Abstract

Pancreatic ductal adenocarcinoma (PDAC) and its precursor lesions, pancreatic intraepithelial neoplasia (PanIN), display a ductal phenotype. However, there is evidence in genetically defined mouse models for PDAC harbouring a mutated kras under the control of a pancreas-specific promoter that ductal cancer might arise in the centroacinar-acinar region, possibly through a process of acinar-ductal metaplasia (ADM). In order to further elucidate this model of PDAC development, an extensive expression analysis and molecular characterization of the putative and already established (PanIN) precursor lesions were performed in the Kras(G12D/+) ; Ptf1a-Cre(ex1/+) mouse model and in human tissues, focusing on lineage markers, developmental pathways, cell cycle regulators, apomucins, and stromal activation markers. The results of this study show that areas of ADM are very frequent in the murine and human pancreas and represent regions of increased proliferation of cells with precursor potential. Moreover, atypical flat lesions originating in areas of ADM are the most probable precursors of PDAC in the Kras(G12D/+); Ptf1a-Cre(ex1/+) mice and similar lesions were also found in the pancreas of three patients with a strong family history of PDAC. In conclusion, PDAC development in Kras(G12D/+); Ptf1a-Cre(ex1/+) mice starts from ADM and a similar process might also take place in patients with a strong family history of PDAC.

摘要

胰腺导管腺癌 (PDAC) 及其前体病变胰腺上皮内瘤变 (PanIN) 表现出导管表型。然而,在受胰腺特异性启动子控制的基因突变型 Kras 定义的遗传小鼠模型中,有证据表明导管癌可能起源于中心腺泡 - 腺泡区域,可能通过腺泡 - 导管化生 (ADM) 的过程。为了进一步阐明这种 PDAC 发展模型,对 Kras(G12D/+) ; Ptf1a-Cre(ex1/+) 小鼠模型和人类组织中的假定和已建立的 (PanIN) 前体病变进行了广泛的表达分析和分子特征分析,重点关注谱系标志物、发育途径、细胞周期调节剂、黏蛋白和基质激活标志物。这项研究的结果表明,ADM 区域在小鼠和人类胰腺中非常常见,代表具有前体潜力的细胞增殖增加的区域。此外,起源于 ADM 区域的非典型扁平病变是 Kras(G12D/+) ; Ptf1a-Cre(ex1/+) 小鼠中 PDAC 最可能的前体,在具有强烈 PDAC 家族史的三名患者的胰腺中也发现了类似的病变。总之,Kras(G12D/+) ; Ptf1a-Cre(ex1/+) 小鼠中的 PDAC 发展始于 ADM,并且在具有强烈 PDAC 家族史的患者中也可能发生类似的过程。

相似文献

1
Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.胰腺导管腺癌源自非典型扁平病变:转基因小鼠和人组织的对比研究。
J Pathol. 2012 Apr;226(5):723-34. doi: 10.1002/path.3017. Epub 2012 Jan 17.
2
Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice.Krüppel 样因子 5 在胰腺导管腺癌中增加,促进增殖、腺泡到导管化生、胰腺上皮内瘤变和肿瘤生长在小鼠中。
Gastroenterology. 2018 Apr;154(5):1494-1508.e13. doi: 10.1053/j.gastro.2017.12.005. Epub 2017 Dec 15.
3
Early requirement of Rac1 in a mouse model of pancreatic cancer.早期 Rac1 在胰腺癌小鼠模型中的需求。
Gastroenterology. 2011 Aug;141(2):719-30, 730.e1-7. doi: 10.1053/j.gastro.2011.04.043. Epub 2011 Apr 28.
4
Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma.起源细胞影响胰腺导管腺癌的肿瘤发生和表型。
Gut. 2019 Mar;68(3):487-498. doi: 10.1136/gutjnl-2017-314426. Epub 2018 Jan 23.
5
PYK2 Is Involved in Premalignant Acinar Cell Reprogramming and Pancreatic Ductal Adenocarcinoma Maintenance by Phosphorylating β-Catenin.PYK2 通过磷酸化β-连环蛋白参与癌前腺泡细胞重编程和胰腺导管腺癌的维持。
Cell Mol Gastroenterol Hepatol. 2019;8(4):561-578. doi: 10.1016/j.jcmgh.2019.07.004. Epub 2019 Jul 19.
6
Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.Smad4失活加速Kras(G12D)介导的胰腺肿瘤形成。
Cancer Res. 2007 Sep 1;67(17):8121-30. doi: 10.1158/0008-5472.CAN-06-4167.
7
Hypothetical progression model of pancreatic cancer with origin in the centroacinar-acinar compartment.起源于中央腺泡-腺泡区室的胰腺癌假设进展模型。
Pancreas. 2007 Oct;35(3):212-7. doi: 10.1097/mpa.0b013e31805d0190.
8
Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia.维持腺泡细胞组织的结构对于预防 Kras 诱导的腺泡-导管化生至关重要。
Oncogene. 2013 Apr 11;32(15):1950-8. doi: 10.1038/onc.2012.210. Epub 2012 Jun 4.
9
The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.基因工程小鼠模型中致癌性 Kras 突变引发的 PanIN 的生物学特征。
Cancer Lett. 2013 Oct 1;339(1):135-43. doi: 10.1016/j.canlet.2013.07.010. Epub 2013 Jul 22.
10
Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.纤维母细胞生长因子受体 4 在高级别胰腺上皮内瘤变和胰腺导管腺癌中的过表达。
Int J Oncol. 2011 Jan;38(1):133-43.

引用本文的文献

1
Precursor lesions in familial and hereditary pancreatic cancer.家族性和遗传性胰腺癌的前驱病变。
Fam Cancer. 2024 Aug;23(3):267-278. doi: 10.1007/s10689-024-00359-2. Epub 2024 Feb 6.
2
Fatty infiltration of the pancreas: a systematic concept analysis.胰腺脂肪浸润:一项系统的概念分析
Front Med (Lausanne). 2023 Sep 22;10:1227188. doi: 10.3389/fmed.2023.1227188. eCollection 2023.
3
Key transcriptional effectors of the pancreatic acinar phenotype and oncogenic transformation.胰腺腺泡表型和致癌转化的关键转录效应因子。
PLoS One. 2023 Oct 5;18(10):e0291512. doi: 10.1371/journal.pone.0291512. eCollection 2023.
4
Current status of molecular diagnostic approaches using liquid biopsy.液体活检中应用的分子诊断方法的现状。
J Gastroenterol. 2023 Sep;58(9):834-847. doi: 10.1007/s00535-023-02024-4. Epub 2023 Jul 20.
5
Comprehensive analysis reveals the potential value of inflammatory response genes in the prognosis, immunity, and drug sensitivity of lung adenocarcinoma.综合分析揭示了炎症反应基因在肺腺癌预后、免疫和药物敏感性中的潜在价值。
BMC Med Genomics. 2022 Sep 18;15(1):198. doi: 10.1186/s12920-022-01340-7.
6
Pharmacological inhibition and reversal of pancreatic acinar ductal metaplasia.胰腺腺泡导管化生的药理学抑制与逆转
Cell Death Discov. 2022 Sep 2;8(1):378. doi: 10.1038/s41420-022-01165-4.
7
Ordered and deterministic cancer genome evolution after p53 loss.p53 失活后有序且确定的癌症基因组进化。
Nature. 2022 Aug;608(7924):795-802. doi: 10.1038/s41586-022-05082-5. Epub 2022 Aug 17.
8
Emerging Role of CREB in Epithelial to Mesenchymal Plasticity of Pancreatic Cancer.CREB在胰腺癌上皮-间质可塑性中的新作用
Front Oncol. 2022 Jun 21;12:925687. doi: 10.3389/fonc.2022.925687. eCollection 2022.
9
Molecular signaling in pancreatic ductal metaplasia: emerging biomarkers for detection and intervention of early pancreatic cancer.胰腺导管化生中的分子信号传导:用于早期胰腺癌检测和干预的新兴生物标志物
Cell Oncol (Dordr). 2022 Apr;45(2):201-225. doi: 10.1007/s13402-022-00664-x. Epub 2022 Mar 15.
10
Deregulation of Transcription Factor Networks Driving Cell Plasticity and Metastasis in Pancreatic Cancer.驱动胰腺癌细胞可塑性和转移的转录因子网络失调
Front Cell Dev Biol. 2021 Nov 23;9:753456. doi: 10.3389/fcell.2021.753456. eCollection 2021.